Clinical Trial Update: CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact [NA]

View source ↗

Summary

An update on the CardioMetabolic program integrating eHealth tools, detailing completion of redesign and evaluation efforts intended to broaden reach and impact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Metabolic Syndrome
• Obesity
• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Palo Alto Medical Foundation | Conditions: Obesity, Metabolic Syndrome | NA | Status: COMPLETED